PECAM1 and endometrial cancer: Furthermore, a comprehensive assessment of PECAM1 across various cancer types revealed that PECAM1 was consistently expressed at low levels compared to normal tissues, including bladder, breast, esophageal, colon, cervical, renal cell, pancreatic, rectal, and endometrial cancers (Figure 9A).